AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-82386116/h-lundbeck-depression-drug.html" title="Facts and information about H. Lundbeck's depression drug approved in Switzerland.(Brief Article)(Product Announcement)">H. Lundbeck's depression drug approved in Switzerland.(Brief Article)(Product Announcement)</a>
Close
Set up an RSS feed that alerts you when new articles from M2 Europharma are available.
Frequently asked questions about RSS feeds
H. Lundbeck's depression drug approved in Switzerland.(Brief Article)(Product Announcement)
M2 EUROPHARMA-(C)1999-2002 M2 COMMUNICATIONS LTD
The Danish pharmaceutical company H. Lundbeck A/S' Cipralex drug has been approved by the Swiss health authorities as a treatment for depression.
Lundbeck now expects to introduce Cipralex in Switzerland during the second quarter of the year. In December 2001 the company received approval from Sweden's health …
Related articles from newspapers, magazines, journals, and more
